Table 3.
Reciprocal PRNT titer |
|||||
---|---|---|---|---|---|
Reciprocal ELISA titer |
75% |
||||
Subject | Week 12 | Week 32 | 50%, week 12 | Week 12 | Week 32 |
A | 480 | 30 | 32 | 16 | 16 |
B | Not done | 90 | Not done | Not done | 8 |
Ca | Negative | Negative | Negative | Negative | Negative |
D | 1920 | 30 | 64 | 32 | 8 |
E | 480 | Negative | 64 | 32 | 16 |
F | 1920 | 30 | 32 | 4 | 8 |
Gb | 120 | 30 | 4 | Negative | 8 |
Hb | 120 | Negative | 2 | Negative | 2 |
I | 480 | 30 | 64 | 32 | 16 |
J | 1920 | 90 | 128 | 16 | 8 |
K | 480 | 90 | 64 | 16 | 32 |
L | 1920 | 90 | 128 | 32 | 16 |
M | 480 | 30 | 64 | 8 | 8 |
N | 7680 | 810 | 16 | 4 | 4 |
O | 480 | 90 | 16 | 16 | 2 |
NOTE. Reciprocal titers are shown for each subject as assessed by ELISA and plaque-reduction neutralization (PRNT) at weeks 12 and 32. Positive responses are reported as a reciprocal titer.
Received 1 dose of vaccine.
Received 2 doses of vaccine.